Arixtra and Ultram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arixtra (fondaparinux sodium) and Ultram (tramadol hydrochloride). Common drug interactions include pneumonia among females and hip fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Arixtra and Ultram. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.



On Jul, 14, 2026

25 people who take Arixtra and Ultram together, and have interactions are studied.

Arixtra and Ultram drug interactions.

What are the common drug interactions of Arixtra and Ultram, by gender? *:

female:

  1. Pneumonia
  2. Arthralgia (joint pain)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Pain in extremity
  5. Peripheral swelling
  6. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  7. Dyspnoea (difficult or laboured respiration)
  8. Chest pain
  9. Drug intolerance (drug sensitivity)
  10. Hypotension (abnormally low blood pressure)

male:

  1. Hip fracture
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Death
  5. Dyspnoea (difficult or laboured respiration)
  6. Gangrene (body tissue dies)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Groin pain
  9. Heparin-induced thrombocytopenia
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Arixtra and Ultram, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chest pain
  2. Drug intolerance (drug sensitivity)
  3. Dyspnoea (difficult or laboured respiration)
  4. Accidental needle stick

50-59:

  1. Arthralgia (joint pain)
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Pain in extremity
  4. Peripheral swelling
  5. Pneumonia
  6. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  7. Activated partial thromboplastin time prolonged
  8. Anaemia (lack of blood)
  9. Catheter related complication
  10. Coagulation time prolonged

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Hip fracture
  3. Pericardial effusion (fluid around the heart)
  4. Pleural effusion (water on the lungs)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Urinary tract infection
  7. Abdominal discomfort
  8. Atelectasis (partial or complete collapse of the lung)
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Cardiac arrest

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 5 people, 20.00%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 16.00%
  3. Insomnia (sleeplessness): 3 people, 12.00%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 8.00%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and Ultram?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arixtra and Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arixtra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arixtra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fondaparinux sodium and tramadol hydrochloride (the active ingredients of Arixtra and Ultram, respectively), and Arixtra and Ultram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: